Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Malaria Consortium is a leading international non-profit organization dedicated to the prevention, control, and treatment of malaria and other communicable diseases among vulnerable populations. Established in 2003, the organization operates extensively across Africa and Southeast Asia, bridging the gap between evidence-based research and large-scale health implementation. Their flagship Seasonal Malaria Chemoprevention (SMC) program reaches millions of children annually, significantly reducing malaria incidence during high-transmission months. Beyond malaria, the consortium provides integrated health services for pneumonia, diarrhea, and neglected tropical diseases, while also strengthening national health systems. By collaborating with governments and global health partners, Malaria Consortium ensures that life-saving interventions are effective, sustainable, and data-driven.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Malaria Consortium.